Research analysts at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) in a research note issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Sorrento Therapeutics stock opened at $0.35 on Thursday. The company’s 50-day moving average price is $0.31 and its […]
StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) in a report published on Wednesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Trading Down 5.1 % Shares of SRNE opened at $0.35 on Wednesday. The company has a debt-to-equity ratio of 0.14, a quick ratio […]
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) in a report published on Tuesday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, Dawson James downgraded shares of Sorrento Therapeutics from a buy rating to a neutral rating in a report on Monday, February 13th. Sorrento Therapeutics Stock […]
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) in a research note released on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. SRNE has been the subject of a number of other research reports. HC Wainwright decreased their price target on Sorrento Therapeutics from $20.00 to $13.00 […]
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) in a research note issued to investors on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research analysts have also recently weighed in on SRNE. Dawson James cut shares of Sorrento Therapeutics from a buy […]